The city of Saint Paul, Minnesota, currently has 2 active clinical trials seeking participants for Parkinson's Disease research studies.
Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD
Recruiting
The purpose of this randomized, double-blind, placebo-controlled study is to assess the efficacy of BIA 28-6156 over placebo in delaying clinical meaningful motor progression over 78 weeks in subjects with Parkinson's disease who have a pathogenic variant in the glucocerebrosidase 1 (GBA1) gene (GBA-PD).
Gender:
All
Ages:
Between 35 years and 80 years
Trial Updated:
05/29/2024
Locations: Struthers Parkinson's Center- East, Saint Paul, Minnesota +1 locations
Conditions: Parkinson's Disease
Intranasal Insulin in Parkinson's Disease
Recruiting
This project will investigate exploratory outcomes related to the effect of intranasal insulin on cognition, mood, apathy and motor performance of subjects with Parkinson's disease over a 3 week period.
Gender:
All
Ages:
Between 41 years and 89 years
Trial Updated:
04/01/2024
Locations: HealthPartners Neuroscience Center, Saint Paul, Minnesota
Conditions: Parkinson Disease